SEMA3F and breast carcinoma: In vitro, exogenous Sema3f inhibits cell attachment and spreading in the breast cancer cell line MCF7, a line that expresses Nrp1 but not Nrp2; this inhibition is blocked by the addition of anti-Nrp1 functional blocking antibody (Nasarre et al., 2003).